SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending after its latest financial report, which announced its first GAAP profit and a new share buyback program, alongside growth in Agentic AI. The market remains divided between those optimistic about the company's profitability and strategic AI focus, and others concerned by what they perceive as conservative revenue growth guidance.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending following its development agreement with Tower Semiconductor to integrate polymer electro-optic modulators into semiconductor manufacturing, which the community views as a major validation for scalable production in the accelerating AI and photonics revolution, intensifying discussions around its future adoption and high short interest.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Escalating Middle East conflict and disruptions to Strait of Hormuz shipping are fueling intense discussions around USO, as reports of tanker attacks raise global oil supply concerns. The community is actively debating whether strategic reserve releases can adequately offset the potential for sustained high oil prices amidst these geopolitical pressures.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending following the announcement of Josh D'Amaro as the new CEO and Dana Walden as Chief Creative Officer, with community discussion centered on whether this leadership shift will spark a turnaround, alongside excitement for Pixar's successful new film "Hoppers" and the ongoing $7 billion share buyback program.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is trending as recent disappointing delivery figures for Q4 2025 and February 2026, coupled with analyst downgrades, fuel community discussions on whether these 'abysmal results' are priced in and what they signal for the broader, highly competitive Chinese EV market.

Vale SA engages in the production and exportation of iron ore, pellets, manganese, and iron alloys. It operates through the following segments: Iron Solutions, Energy Transition Materials and Others. The Iron Solutions segment includes the production and extraction of iron ore, iron ore pellets, manganese, other ferrous products, and logistic services. The Energy Transition Materials segment involves the production and extraction of nickel and its by-products. Others includes the revenues and cost of other products, services, research and development, investments in joint ventures and associates of other business. The company was founded on June 1, 1942 and is headquartered in Rio de Janeiro, Brazil.

Vale S.A. - ADR

Vale S.A.

Vale is gaining attention as robust production results, notably its highest quarterly iron ore output in years and strong copper performance, reinforce a bullish outlook amidst a broader commodity supercycle. The community is actively discussing its perceived undervaluation, high dividend yield, and significant upside potential despite recent operational halts and mixed sentiment regarding Chinese demand.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as its upcoming 10-K filing deadline approaches, driving community focus on its perceived deep undervaluation relative to appreciating asset holdings like $BW and $APLD, alongside high short interest and accusations of persistent price manipulation.

Rydex Investments - Invesco CurrencyShares Euro Trust

Invesco CurrencyShares Euro Trust

FXE is actively discussed as the Euro grapples with volatility against the US Dollar amidst ongoing global geopolitical tensions and divergent central bank policies, with the community closely watching how Federal Reserve rate expectations and energy prices impact the Euro's near-term trajectory.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the community reacts to its first-ever quarterly profit, driven by strong deliveries and improved margins, alongside excitement for its advanced in-house AI chip and unique battery swap ecosystem. While many view this as a significant turnaround, others remain cautious due to historical price volatility and concerns over market manipulation.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

IXHL is trending due to its imminent Nasdaq compliance, with the community highly anticipating positive news for its Fast Tracked sleep apnea drug, IHL-42X, driving speculation of a short squeeze amid beliefs of significant undervaluation against its pipeline and cash.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki, rejecting California’s attempt to delay the deal over privacy concerns.&nbsp;Judge Brian Walsh said California’s appeal is likely to fail and that consumers remain free to delete their data, according to a Reuters&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/california-fails-stop-23andme-founder-re-acquiring-company-2025-07-07/">report</a>.On July 2,&nbsp;<a href="https://stocktwits.com/symbol/MEHCQ">23andMe</a> confirmed the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/23and-me-co-founder-anne-wojcicki-wins-back-company-in-305-m-deal-beating-regeneron-s-bid/chF03X0RTJd">sale</a> of “substantially all” of its assets, including its core Personal Genome Service, research unit, and Lemonaid Health, to TTAM.&nbsp;The transaction, approved by the U.S. Bankruptcy Court for the Eastern District of Missouri, is expected to close in the coming weeks.California, backed by states like New York and Texas, argued the sale violated genetic privacy laws and could lead to the unauthorized transfer of DNA data.&nbsp;The state said 1.8 million California customers were affected.&nbsp;Walsh dismissed the concerns, citing existing user rights and TTAM’s commitment to upholding privacy policies.TTAM outbid&nbsp;<a href="https://stocktwits.com/symbol/REGN">Regeneron Pharmaceuticals'</a>&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/regeneron-to-buy-assets-of-23andme/ch0cpqfRbFD">$256 million offer</a> in a court-supervised process.&nbsp;Wojcicki, who resigned as CEO earlier this year to make an independent bid, said operating as a nonprofit will better align with 23andMe’s mission to promote public understanding of DNA.On Stocktwits, retail sentiment for&nbsp;23andMe was ‘bearish’ amid ‘extremely low’ message volume.23andMe’s stock has risen 35.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

23andMe Founder and Board Member Anne Wojcicki appears during a House Committee on Oversight and Government Reform hearing on June 10, 2025 in Washington, DC. 

23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA Privacy

A U.S. bankruptcy judge ruled that California's appeal to block the deal was unlikely to succeed, rejecting claims that the sale violated state genetic privacy laws.

Equity

23andMe Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research Institute, a California-based nonprofit led by company co-founder and former CEO Anne Wojcicki.&nbsp;The $305 million transaction is expected to close in the coming weeks.The deal, approved by the U.S. Bankruptcy Court for the Eastern District of Missouri, includes the company’s core Personal Genome Service, research services, and its telehealth subsidiary Lemonaid Health.&nbsp;TTAM will assume control of the company’s ongoing operations with plans to relaunch it as a nonprofit.The court’s approval concludes a months-long sale process that began after&nbsp;<a href="https://stocktwits.com/symbol/MEHCQ">23andMe</a>&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/23andme-stock-jumps-after-court-approves-bankruptcy-asset-sale/chJ322ARbEo">filed for Chapter 11</a> bankruptcy in March.&nbsp;At that time, the company secured initial court authorization for key motions, including wage payments, vendor compensation, and a $35 million debtor-in-possession financing deal with JMB Capital Partners.&nbsp;A formal sale process followed, led by Moelis &amp; Co., which required any buyer to honor 23andMe’s existing consumer privacy policies.In May,&nbsp;<a href="https://stocktwits.com/symbol/REGN">Regeneron Pharmaceuticals</a>&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/regeneron-to-buy-assets-of-23andme/ch0cpqfRbFD">agreed to acquire</a> most of 23andMe’s assets for $256 million.&nbsp;That bid excluded Lemonaid Health and was positioned to expand Regeneron’s capabilities in genetics-driven drug development.&nbsp;However, Wojcicki’s TTAM offer ultimately prevailed in the court-supervised auction.TTAM has committed to&nbsp;upholding 23andMe’s customer privacy standards and stated that it will implement additional safeguards.&nbsp;Customers will receive advance notice ahead of the transaction’s close, with information on how to delete their data or opt out of research.&nbsp;Wojcicki, who resigned as CEO earlier this year to position herself as an independent bidder, said the nonprofit structure will better support 23andMe’s founding mission.&nbsp;“As a nonprofit, TTAM will be a champion of improving our knowledge of DNA – the code of life – for the public good,” she said. “Individuals should be empowered to have choice and transparency with respect to their genetic data.”On Stocktwits, retail sentiment for 23andMe Holding was ‘bullish’ amid ‘low’ message volume.Shares of Regeneron Pharmaceuticals ended up 1.9% on Tuesday. However, the stock declined 25.2% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid

The deal encompasses 23andMe’s core genome testing service, research operations, and Lemonaid Health, with TTAM set to relaunch the company as a nonprofit organization committed to upholding existing data privacy policies.

Chrome Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcicki in 2006 and is headquartered in San Francisco, CA.

MEHCQ
23andMe Holding Co

Feed

News

Sentiment

Fundamentals

Info

Latest MEHCQ News

MEHCQ23andMe Holding Co